HCPCS code K0455: Infusion pump for parenteral medication

Key takeaways

HCPCS code K0455 covers infusion pumps that deliver medication without interruption, most often epoprostenol or treprostinil for pulmonary arterial hypertension.

Suppliers bill K0455 under Medicare Part B as durable medical equipment, through the DME MAC that covers the patient’s region.

Coverage sits under LCD L33794, which requires a signed physician order and records showing why the parenteral route is necessary.

A missing KX modifier is the most common reason a K0455 claim denies on first submission.

Practice management software like Pabau tracks prior authorization status, stores documentation, and flags missing modifiers before a claim goes out.

HCPCS code K0455 is the billable code for an infusion pump used for uninterrupted parenteral administration of medication, such as epoprostenol or treprostinil. Suppliers bill it to Medicare Part B as durable medical equipment. Most claims cover pulmonary arterial hypertension patients on continuous prostacyclin therapy.

K codes are temporary HCPCS Level II codes maintained by CMS specifically for DME items not yet covered by a permanent code. K0455 sits in the K0455-K0605 range, which covers infusion pump hardware and the supply items DME suppliers bill alongside it.

Clinical indications: When K0455 applies

K0455 covers a narrow class of pumps: those built for continuous, uninterrupted parenteral delivery. In practice that means stopping the pump would carry clinically significant consequences. Pulmonary arterial hypertension (PAH) is the primary covered indication, though LCD L33794 recognizes several others.

Sorting K0455 from the other infusion codes is the first decision on any claim. Practices that bill infusion services often build that decision into their IV therapy EMR, so the code is set at the point of care.

Covered indications under LCD L33794

• Pulmonary arterial hypertension (PAH) treated with continuous IV epoprostenol (Flolan) or subcutaneous or IV treprostinil (Remodulin). This is the primary and most common indication.
• Chemotherapy requiring continuous infusion where an ambulatory pump is medically necessary
• Intractable pain unresponsive to oral or other routes of analgesia
• Continuous morphine infusion for intractable cancer pain
• Other medically necessary conditions where the treating physician documents that the parenteral route is required and the medication cannot be interrupted

Non-covered indications

• Infusion pumps used for medications that can be safely interrupted or given by alternate routes
• Pumps provided primarily for patient convenience rather than clinical necessity
• Infusion of medications not approved under the applicable LCD covered drug list
• Pumps used in an inpatient setting where the facility is responsible for DME

The distinction between covered and non-covered indications must appear explicitly in the treating physician’s notes before billing. Vague language like “patient requires IV medication” is insufficient.

K0455 Medicare coverage: LCD L33794 explained

Medicare Part B covers K0455 as DME under the External Infusion Pumps Local Coverage Determination, LCD L33794. These claims are administered by Noridian (Jurisdictions A and D) and CGS (Jurisdictions B and C). Coverage is conditional rather than automatic, so every claim has to demonstrate medical necessity against the LCD criteria.

Practices running a mobile IV therapy business or a fixed infusion center should review LCD L33794 every year. CMS may revise covered indications, add non-covered diagnoses, or adjust documentation standards between fiscal years.

K0455 fee schedule and reimbursement rates

Medicare reimbursement for K0455 follows the DME fee schedule, which CMS updates annually. Rates vary by jurisdiction and by the modifier applied. The modifier says whether the pump is rented, purchased new, or purchased used, and each carries a different allowed amount.

Verify current-year rates against the DMEPOS fee schedule files that CMS publishes. The table below shows the billing framework. Dollar amounts change each fiscal year and vary by geographic region.

Regional variation is standard across DME fee schedules. Suppliers billing in high-cost metropolitan areas may see higher allowed amounts than those billing in rural jurisdictions. Check the figure for your own jurisdiction before you quote a rate to a referring practice.

ICD-10 codes that support medical necessity for K0455

Every K0455 claim must carry an ICD-10-CM diagnosis code that appears on the LCD L33794 covered diagnosis list. A code that is off the list denies automatically, however well the medical necessity is documented. The table below covers the most common ones. Confirm the full current list against the live LCD or the AAPC HCPCS lookup.

Using a non-specific symptom code from the R00-R99 range to support K0455 is a common error that triggers denial. The ICD-10-CM code has to reflect a confirmed, documented diagnosis rather than a symptom or a rule-out condition. Capturing that diagnosis on your IV therapy intake forms and coding it at the point of care saves rework downstream.

K0455 documentation requirements

Documentation deficiencies are the leading cause of post-payment recovery in DME MAC audits of infusion pump claims. Collect the paperwork before the pump is delivered, not once an audit opens. A signed order and a clear medical necessity letter from the prescriber anchor the file.

Collecting that paperwork on digital forms removes the missing signatures and blank fields that cause denials. Every K0455 claim needs the following on file.

• Physician’s written order: Specifies the medication name, concentration, rate, route (IV or subcutaneous), and pump specifications. Must be dated before delivery.
• Medical-record documentation of necessity: Chart notes addressing every LCD L33794 clinical criterion the KX modifier attests to. CMS retired the CMN and Form 484 for dates of service from January 1, 2023.
• Clinical notes establishing diagnosis: Records from the treating cardiologist, pulmonologist, or oncologist confirming the covered ICD-10-CM diagnosis.
• Documentation of alternative therapy failure: For PAH claims, records showing why oral or inhaled alternatives are insufficient or contraindicated. The notes should name the parenteral prostacyclin prescribed.
• Pump delivery confirmation: Proof that the equipment was delivered to the patient (delivery receipt signed by patient or authorized representative).
• Ongoing follow-up notes: For rental claims running past the initial period, documentation of continued medical necessity at each renewal.

Retain every record for at least seven years. DME MAC post-payment audits reach back several years, and an incomplete file leaves the supplier liable for full recoupment.

Prior authorization for K0455

Traditional Medicare has no national prior authorization requirement for K0455, but the answer changes by payer. Many commercial payers and Medicaid managed care plans do require authorization before an infusion pump is delivered. Even under traditional Medicare, the DME MAC may request pre-claim review for high-cost or high-volume suppliers.

Authorization rules are payer-specific, as anyone handling IV hydration compliance already knows. Check the payer policy for every new patient before you schedule delivery. Submitting a commercial claim without the authorization on file usually means a full denial with no appeal path.

• Traditional Medicare (Fee-for-Service): No universal prior authorization requirement, but DME MACs may conduct pre-claim review programs for selected DME categories. Check your jurisdiction’s DME MAC website for active review programs.
• Medicare Advantage Plans: Prior authorization is required by most Medicare Advantage plans for K0455. Contact the plan directly before delivery.
• Commercial payers: Most commercial insurers require prior authorization for ambulatory infusion pumps. Timelines range from 3 to 10 business days.
• Medicaid (state-by-state): Prior authorization requirements and covered indications vary significantly. Verify with the state Medicaid program or managed care plan.

Modifiers used with K0455

Modifier selection determines both whether the claim processes and what the allowed amount will be. Every K0455 claim requires at least two modifiers. One indicates purchase or rental status, and the KX modifier confirms that LCD criteria are met. Submitting without KX is the single most common reason clean-looking K0455 claims deny on first submission.

Related HCPCS codes in the K0455-K0605 infusion pump range

K0455 covers the pump hardware only. Suppliers need additional codes from the K0455-K0605 range for the associated supplies, accessories, and disposables. Billing K0455 for a supply item that has its own code is a compliance error that can trigger recoupment. Mapping every item in the kit to its own code before submission prevents that, and EHR integration keeps the mapping in one place.

Common billing errors and compliance tips for K0455

DME infusion pump claims carry one of the highest post-payment audit recovery rates in the Part B DME benefit. Most recoveries trace back to a small set of repeatable errors. Anyone opening an IV therapy clinic with a DME supply line should build checks around these failure points from day one.

• Missing KX modifier: The most common denial. KX must appear on every K0455 claim to signal that documentation supporting LCD coverage is on file. Its absence results in automatic denial with no right of appeal.
• Insufficient medical necessity documentation: Claims clear front-end edits but fail on audit when the notes skip the reasoning. They must say why the parenteral route is required and why alternatives are inadequate. “Patient needs IV medication” is not enough.
• Wrong payer routing: K0455 for Medicare patients goes to the DME MAC for the patient’s region, not the A/B MAC that handles physician claims. The wrong contractor means denial or redirection.
• Rental and purchase modifier mismatch: Billing NU when the arrangement is a rental, or the reverse, creates a billing integrity issue. It can also trigger fraud and abuse scrutiny.
• Unsupported ICD-10-CM code: Using a diagnosis code not on the LCD L33794 covered diagnosis list, even with strong clinical documentation, results in denial. The code must match the LCD list exactly.
• Missing delivery documentation: Suppliers must retain proof of delivery signed by the patient. Without it, payment is recoupable on audit regardless of the clinical justification.

How practice management software supports K0455 billing

DME infusion pump billing pairs strict documentation rules with modifier logic and payer-specific authorization. Tracking that by hand across a caseload is where suppliers lose money. Each patient has their own review dates, authorization expiry, and ICD-10-CM crosswalk to keep straight.

IV therapy EMR software built for infusion practices takes over the parts of that workload that break down first. Pabau’s claims management software attaches documentation to each claim, flags a missing modifier before submission, and shows prior authorization status by payer.

Automated workflows cover the calendar side, with reminders for reauthorization and documentation reviews. Nothing submits without the paperwork K0455 requires. Pabau also works as wellness practice software, so a practice adding infusion services keeps notes and billing in one record.

Digital intake and clinical forms capture physician orders and medical necessity statements as structured fields from the start of care. That matters when a DME MAC auditor asks for the record three years after delivery.

Streamline your DME billing and prior authorization tracking

Pabau tracks prior authorization status, stores compliance documentation, and flags missing modifiers before submission. Infusion practices and DME suppliers get accurate HCPCS claims without the paperwork burden.

Book a demo

Conclusion

K0455 rewards suppliers who treat documentation as part of delivery, not paperwork to chase later. The order, the covered diagnosis, and the notes justifying the parenteral route all have to exist before the pump leaves the warehouse.

The trade-off worth remembering is timing. Collecting the records up front costs a few minutes per patient. Rebuilding them for an audit three years later can cost the whole payment. Book a demo to see how Pabau keeps K0455 documentation, modifiers, and authorizations in one place.

Continue your research

Need the prescriber letter that carries the necessity argument? Medical necessity letter template gives you a structure auditors can follow.

Billing other durable medical equipment alongside the pump? E0371 walks through the coverage criteria and documentation a DME MAC expects.

Working through another LCD-governed DME claim? L0622 covers the order, the modifiers, and the records that support payment.

Billing the drug as well as the device? J1562 explains units, documentation, and the errors that hold up payment.

Running an infusion suite with mixed payers? J1450 shows how unit-based drug billing works next to a device claim.

Frequently asked questions